StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Vaccinex's operating cash flow for the twelve months ending Dec 31, 2024 was -$16.19M. For fiscal 2024 it was -$16.19M. The highest annual figure on record is -$16.19M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$16.19M–
FY2023Dec 31, 2023-$21.38M–
FY2022Dec 31, 2022-$19.07M–
FY2021Dec 31, 2021-$25.30M–
FY2020Dec 31, 2020-$28.65M–
FY2019Dec 31, 2019-$30.72M–
FY2018Dec 31, 2018-$25.28M–
FY2017Dec 31, 2017-$21.39M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$3.93M–
Q3 FY2024Sep 30, 2024-$3.21M–
Q2 FY2024Jun 30, 2024-$4.42M–
Q1 FY2024Mar 31, 2024-$4.63M–
Q4 FY2023Dec 31, 2023-$7.74M–
Q3 FY2023Sep 30, 2023-$3.10M–
Q2 FY2023Jun 30, 2023-$5.51M–
Q1 FY2023Mar 31, 2023-$5.04M–
Q4 FY2022Dec 31, 2022-$4.60M–
Q3 FY2022Sep 30, 2022-$4.15M–
Q2 FY2022Jun 30, 2022-$5.33M–
Q1 FY2022Mar 31, 2022-$5.00M–
Q4 FY2021Dec 31, 2021-$5.14M–
Q3 FY2021Sep 30, 2021-$6.06M–
Q2 FY2021Jun 30, 2021-$6.98M–
Q1 FY2021Mar 31, 2021-$7.11M–
Q4 FY2020Dec 31, 2020-$6.38M–
Q3 FY2020Sep 30, 2020-$9.31M–
Q2 FY2020Jun 30, 2020-$5.45M–
Q1 FY2020Mar 31, 2020-$7.51M–
Q4 FY2019Dec 31, 2019-$5.80M–
Q3 FY2019Sep 30, 2019-$10.49M–
Q2 FY2019Jun 30, 2019-$5.95M–
Q1 FY2019Mar 31, 2019-$8.48M–
Q4 FY2018Dec 31, 2018-$7.56M–
Q3 FY2018Sep 30, 2018-$7.22M–
Q2 FY2018Jun 30, 2018-$5.33M–
Q1 FY2018Mar 31, 2018-$5.17M–
Q4 FY2017Dec 31, 2017-$6.25M–
Q3 FY2017Sep 30, 2017-$4.73M–

More Vaccinex figures

See a number that looks wrong?